Biopharma could reap benefits from SVB UK acquisition
One of the largest banking collapses in US history could…
One of the largest banking collapses in US history could provide the biotech sector unseen opportunities, say GlobalData.
List view / Grid view
One of the largest banking collapses in US history could…
One of the largest banking collapses in US history could provide the biotech sector unseen opportunities, say GlobalData.
The top 20 biopharma companies averaged a market capitalisation decline…
The top 20 biopharma companies averaged a market capitalisation decline of $3.45 trillion in Q2 to $3.14 trillion in Q3 2022, says GlobalData.